AstraZeneca PLC
AZN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $203,112 | $210,401 | $209,909 | $165,197 |
| - Cash | $5,488 | $5,840 | $6,166 | $6,329 |
| + Debt | $30,114 | $28,622 | $29,143 | $30,688 |
| Enterprise Value | $227,738 | $233,183 | $232,886 | $189,556 |
| Revenue | $54,073 | $45,811 | $44,351 | $37,417 |
| % Growth | 18% | 3.3% | 18.5% | – |
| Gross Profit | $43,866 | $37,543 | $31,960 | $24,980 |
| % Margin | 81.1% | 82% | 72.1% | 66.8% |
| EBITDA | $15,438 | $13,422 | $9,085 | $5,113 |
| % Margin | 28.6% | 29.3% | 20.5% | 13.7% |
| Net Income | $7,035 | $5,955 | $3,288 | $112 |
| % Margin | 13% | 13% | 7.4% | 0.3% |
| EPS Diluted | 1.13 | 1.91 | 1.06 | 0.04 |
| % Growth | -40.8% | 80.2% | 2,550% | – |
| Operating Cash Flow | $11,861 | $10,345 | $9,808 | $5,963 |
| Capital Expenditures | -$4,586 | -$3,778 | -$2,571 | -$2,200 |
| Free Cash Flow | $7,275 | $6,567 | $7,237 | $3,763 |